IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV11I13A300

Successful treatment of an iatrogenic membranous ventricular septal defect (IVSD) following Edwards SAPIEN 3 implantation by a valve-in-valve procedure

Tanja K. Rudolph1*, MD; Maximilian Scherner2, MD; Elmar Kuhn2, MD; Volker Rudolph1, MD; Victor Mauri1, MD; Stephan Rosenkranz1, MD; Thorsten Wahlers2, MD; Stephan Baldus1, MD; Navid Mader2, MD

Iatrogenic membranous ventricular septal defects (IVSD) are a rare complication of transcatheter aortic valve implantation (TAVI), mainly attributed to post-dilation and excessive calcification in the left ventricular outflow tract (LVOT). We report a case of IVSD following implantation of an Edwards SAPIEN 3 transcatheter heart valve (Edwards Lifesciences, Irvine, CA, USA) which was successfully treated by a valve-in-valve procedure.

A 79-year-old male with heavily calcified aortic valve and calcification in the LVOT underwent TAVI. Following predilatation, a 29 mm SAPIEN 3 prosthesis was deployed uneventfully. Over the next 12 hours the patient developed right ventricular failure. Echocardiography showed an IVSD with a haemodynamically relevant left-to-right shunt. CT revealed that the prosthesis lying at the upper rim of calcification spots in the LVOT had caused a tear along the calcification. Since the patient deteriorated over the following eight hours, a second 26 mm SAPIEN 3 prosthesis was implanted uneventfully at a lower position within the LVOT to close the IVSD. Transoesophageal echocardiography (TEE) revealed a minimal residual IVSD, no paravalvular leak (PVL) and ∆Pmean=5 mmHg. Due to postoperative 3rd degree atrioventricular (AV) block, a pacemaker was implanted. A transthoracic echocardiogram (TTE) after two months showed persistent minimal IVSD jet. Left and right ventricular function were preserved and the patient was asymptomatic.

Conflict of interest statement

T. Rudolph, S. Baldus, T. Wahlers and N. Mader are proctors for Edwards Lifesciences. The other authors have no conflicts of interest to declare.

Supplementary data

Online Figure 1. CT and echocardiographic images.

Online Figure 1. CT and echocardiographic images. A) Preoperative CT scan revealed a symmetrically severely calcified aortic valve and two prominent spike-like calcifications in the LVOT (B). C) Final position of the SAPIEN 3 (29 mm). D) Postoperative TTE and TEE (E) showed an IVSD with significant left-to-right shunt. F) Prosthesis at the upper rim of LVOT calcification (CT scan). G) After implanting the second SAPIEN 3 (26 mm), intraoperative TEE revealed a minimal residual IVSD jet. H) Small jet from the left into the right ventricle at two-month follow-up.

Volume 11 Number 13
Apr 20, 2016
Volume 11 Number 13
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJY15M02_06 Jul 20, 2015
Transcatheter Lotus valve implantation in a regurgitant SAPIEN 3 valve
Van Mieghem NM et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV11I11A255 Feb 12, 2016
Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report
Molina-Martin de Nicolas J et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00737 Apr 20, 2018
Intracardiac shunts following transcatheter aortic valve implantation: a multicentre study
Amat-Santos I et al
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved